Form 4: Avanos Medical SVP Michael Greiner Reports Stock Transaction
SEC Form 4 Filing
Michael Greiner, SVP and CFO of Avanos Medical, reports the disposition of shares to cover tax obligations upon vesting of restricted stock units.
Summary
- On March 5, 2024, Michael Greiner, the SVP and Chief Financial Officer of Avanos Medical, Inc. (AVNS), reported a transaction involving common stock.
- Greiner disposed of 4,991 shares of common stock at a price of $18.76 per share to satisfy tax withholding obligations.
- This transaction occurred due to the vesting of time-based restricted share units (TRSUs) awarded on March 4, 2022.
- Following the transaction, Greiner beneficially owns 106,312 shares of Avanos Medical, Inc.
- The TRSUs vest in three tranches: 1/3 vested on March 4, 2023, 1/3 vested on March 4, 2024, and the remaining 1/3 will vest on March 4, 2025.
Sentiment
Score: 5
Explanation: This is a routine transaction related to executive compensation and does not indicate any significant positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This transaction is related to the vesting of previously granted stock awards, a common practice for executive compensation.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, as it is a routine part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/04/2022 | Date of the original grant of time-based restricted share units (TRSUs). |
| 03/04/2023 | Date when 1/3 of the TRSUs vested. |
| 03/04/2024 | Date when another 1/3 of the TRSUs vested. |
| 03/05/2024 | Date of the stock transaction where shares were disposed of to cover tax obligations. |
| 03/06/2024 | Date of signature on the Form 4 filing. |
| 03/04/2025 | Date when the remaining 1/3 of the TRSUs will vest. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.